» Authors » Berta Gonzalez

Berta Gonzalez

Explore the profile of Berta Gonzalez including associated specialties, affiliations and a list of published articles. Areas
Snapshot
Articles 59
Citations 1394
Followers 0
Related Specialties
Top 10 Co-Authors
Published In
Affiliations
Soon will be listed here.
Recent Articles
1.
Peris M, Benseny-Cases N, Manich G, Zerpa O, Almolda B, Peralvarez-Marin A, et al.
ACS Chem Neurosci . 2023 Aug; 14(17):3088-3102. PMID: 37540627
Key events in postnatal brain development, such as neuronal migration, synaptogenesis, and myelination, shape the adult brain. These events are reflected in changes in gray and white matter (GM and...
2.
Ochoa-Fernandez B, Galan-Gomez V, Guerra-Garcia P, Sanroman S, Martinez I, Bueno D, et al.
Front Pediatr . 2023 Jun; 11:1166176. PMID: 37325355
Objectives: This study aimed to evaluate the characteristics and outcomes of infant patients with leukemia. Methods: A retrospective analysis was conducted in a cohort of 39 patients diagnosed with infant...
3.
Salmeron-Villalobos J, Castrejon-de-Anta N, Guerra-Garcia P, Ramis-Zaldivar J, Lopez-Guerra M, Mato S, et al.
Blood . 2023 Apr; 142(5):434-445. PMID: 37053555
Posttransplant lymphoproliferative disorders (PTLDs) represent a broad spectrum of lymphoid proliferations, frequently associated with Epstein-Barr virus (EBV) infection. The molecular profile of pediatric monomorphic PTLDs (mPTLDs) has not been elucidated,...
4.
Paolicelli R, Sierra A, Stevens B, Tremblay M, Aguzzi A, Ajami B, et al.
Neuron . 2022 Nov; 110(21):3458-3483. PMID: 36327895
Microglial research has advanced considerably in recent decades yet has been constrained by a rolling series of dichotomies such as "resting versus activated" and "M1 versus M2." This dualistic classification...
5.
Ghorashian S, Jacoby E, De Moerloose B, Rives S, Bonney D, Shenton G, et al.
Lancet Haematol . 2022 Sep; 9(10):e766-e775. PMID: 36084658
Background: Children aged younger than 3 years were excluded from the ELIANA phase 2 trial of tisagenlecleucel in children with acute lymphoblastic leukaemia. The feasibility, safety, and activity of tisagenlecleucel...
6.
Galan-Gomez V, Gonzalez B, Vasserot I, Mirones I, Perez-Martinez A
An Pediatr (Engl Ed) . 2022 Jul; 97(2):131-134. PMID: 35788337
No abstract available.
7.
Shanaki-Bavarsad M, Almolda B, Gonzalez B, Castellano B
Exp Neurobiol . 2022 Jul; 31(3):173-195. PMID: 35786640
Traumatic brain injury is the greatest cause of disability and death in young adults in the developed world. The outcome for a TBI patient is determined by the severity of...
8.
Galan-Gomez V, Matamala N, Ruz-Caracuel B, Valle-Simon P, Ochoa-Fernandez B, Guerra-Garcia P, et al.
J Pers Med . 2022 Jun; 12(6). PMID: 35743666
Relapsed and refractory (R/r) disease in paediatric acute leukaemia remains the first reason for treatment failure. Advances in molecular characterisation can ameliorate the identification of genetic biomarkers treatment strategies for...
9.
Enrich-Bengoa J, Manich G, Valente T, Sanchez-Molina P, Almolda B, Sola C, et al.
Int J Mol Sci . 2022 Apr; 23(7). PMID: 35408977
Transient potential receptor vanilloid 2 (TRPV2) is widely expressed through the nervous system and specifically found in neuronal subpopulations and some glial cells. TRPV2 is known to be sensitized by...
10.
Fernandez A, Perez-Martinez A, Escudero A, Mirones I, Gonzalez B, de Paz R, et al.
Leuk Lymphoma . 2022 Apr; 63(8):1970-1974. PMID: 35369829
No abstract available.